Photocure ASA Logo

Photocure ASA

Develops and commercializes photodynamic technology for bladder cancer.

PHO | OL

Overview

Corporate Details

ISIN(s):
NO0010000045
LEI:
5967007LIEEXZXG8OW35
Country:
Norway
Address:
HOFFSVEIEN 4, 0275 OSLO

Description

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-02-11 09:05
Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Tr…
English 188.0 KB
2022-02-11 09:05
Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Tr…
English 7.2 KB
2022-02-08 14:07
Major shareholder disclosure in Photocure ASA
English 126.6 KB
2022-02-08 14:07
Major shareholder disclosure in Photocure ASA
English 296 bytes
2022-02-07 06:23
Bladder Cancer technology: New improved Blue Light Cystoscopy system receives F…
English 189.9 KB
2022-02-07 06:23
Bladder Cancer technology: New improved Blue Light Cystoscopy system receives F…
English 7.2 KB
2022-02-04 07:10
Photocure ASA – Major shareholding disclosure
English 853 bytes
2022-01-20 07:56
Major shareholder disclosure - Photocure ASA
English 129.4 KB
2022-01-20 07:56
Major shareholder disclosure - Photocure ASA
English 287 bytes
2021-12-21 12:15
Financial calendar
English 644 bytes
2021-12-20 09:04
Financial calendar
English 614 bytes
2021-12-09 13:17
Photocure ASA: Share capital increase registered
English 109.4 KB
2021-12-09 13:17
Photocure ASA: Share capital increase registered
English 1.6 KB
2021-12-06 19:15
Photocure ASA: Exercise of employee share options
English 86.7 KB
2021-12-06 19:15
Photocure ASA: Exercise of employee share options
English 111.1 KB

Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Photocure ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Photocure ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.